The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide


HOUSSIAU F. A. , VASCONCELOS C., D'CRUZ D., SEBASTIANI G. D. , DE RAMON GARRIDO E., DANIELI M. G. , ...Daha Fazla

ANNALS OF THE RHEUMATIC DISEASES, cilt.69, ss.61-64, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 69 Konu: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1136/ard.2008.102533
  • Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
  • Sayfa Sayıları: ss.61-64

Özet

Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative lupus nephritis.